Clinical Research and Medical Studies in Hair Restoration at Elithair
Elithair’s research initiatives focus on the continuous improvement of hair restoration methods and clinical outcomes.
Guided by experienced medical specialists, ongoing studies support the refinement of advanced techniques, such as our NEO FUE, with the goal of delivering reliable, individualized results.
Through the systematic evaluation of treatment performance and patient experience, Elithair’s research efforts contribute to evidence-based progress in hair restoration—ensuring that medical quality and patient confidence remain central to every development.
Ongoing Hair Restoration Studies Conducted by Elithair
Research is only worth something if it can be checked. That is why Elithair publishes its findings rather than keeping them in-house—including the studies that are still running. Below is an overview of the research and publications that inform how we work:
Hair Transplant Patient Satisfaction Study (Ongoing Since 2022)
At Elithair, patient satisfaction is not a one-time survey but a continuous measurement: the study has been running since July 2022 and is still ongoing.
Across that entire period, the share of patients who would recommend Elithair has remained constant at 98–99%. That consistency, rather than any single figure, is what counts as the meaningful result—and it is why patient feedback stays a permanent part of Elithair’s quality process.
Study on the Effectiveness of Ingredients Used in Elithair Products
Elithair evaluates the ingredients used in its hair care products as part of its broader research efforts. Developed under the medical guidance of Dr. Balwi, these formulations are designed to support hair restoration and post-treatment care. The evaluation looks at each of the selected ingredients individually and examines its role in supporting hair health and treatment outcomes, based on the available data and analysis.
Study on the Impact of Energy Drink Consumption on Hair Loss in Adults
Energy drink consumption is common among adults, with approximately 30% reporting regular use and an estimated 12% classified as high or chronic consumers, averaging around 4.5 liters per month. As part of Elithair’s research initiatives, Dr. Balwi examines whether frequent energy drink intake may be associated with hair loss in adults. The study explores potential correlations between consumption habits and hair health, offering data-driven insights into lifestyle factors that may influence hair loss. Full study findings are available for those seeking a deeper understanding of the topic.
Hair Transplant Procedures in Patients With Diabetes
Whether individuals with diabetes can safely undergo a hair transplant is a common clinical question. To address this, Elithair conducted a seven-month internal study involving 53 participants diagnosed with diabetes. The study examines treatment planning, procedural considerations, and observed outcomes in this patient group, providing insight into safety aspects and clinical feasibility. Full details and findings are available in the complete study.
Publication by Dr. Abdulaziz Balwi: Sustainable Donor Area Planning
How can a donor area stay healthy and dense over the long term? That is the question Elithair’s lead physician, Dr. Abdulaziz Balwi, takes up in a paper published in the international journal Cosmetics. He lays out a clear clinical framework: measure every donor area individually, stay conservative with extraction volumes, and plan for possible future sessions from the start. The full publication explains why restraint and early planning ultimately determine the outcome at Elithair.
Publication by Dr. Abdulaziz Balwi: Regenerative Therapies in Hair Transplantation
What do PRP, exosomes, and laser therapy actually add as supportive treatments? Elithair’s lead physician, Dr. Abdulaziz Balwi, took on that question in Frontiers in Medicine with a systematic review of the available research. His paper shows which procedures are backed by solid evidence, where the research is still thin, and why standardized treatment protocols matter. The full publication spells out the scientific basis Elithair uses when choosing supportive therapies.